Author:
Razumovskaya A. V.,Silkina M. O.,Nikulin S. V.,Tonevitsky A. G.,Alekseev B. Ya.
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Chhikara BS, Parang K. Global Cancer Statistics 2022: the trends projection analysis. Chem. Biol. Letters. 2023;10(1):451. URL: https://pubs.thesciencein.org/journal/index.php/cbl/article/view/451
2. He X, Jiang Y, Zhang L, Li Y, Hu X, Hua G, Cai S, Mo S, Peng J. Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer. Front. Bioeng. Biotechnol. 2023;11:1190637. doi: https://doi.org/10.3389/fbioe.2023.1190637
3. Ji DB, Wu AW. Organoid in colorectal cancer: progress and challenges. Chin. Med. J. (Engl). 2020;133(16):1971-1977. doi: https://doi.org/10.1097/CM9.0000000000000882
4. Sasaki N, Clevers H. Studying cellular heterogeneity and drug sensitivity in colorectal cancer using organoid technology. Curr. Opin. Genet. Dev. 2018;52:117-122. doi: https://doi.org/10.1016/j.gde.2018.09.001
5. Pattabiraman DR, Weinberg RA. Tackling the cancer stem cells — what challenges do they pose? Nat. Rev. Drug Discov. 2014;13(7):497-512. doi: https://doi.org/10.1038/nrd4253